home
portfolio
team
careers
contact
investor portal
home
portfolio
team
careers
contact
investor portal
Nextech Invest
Kronos Bio Reports Recent Business Progress and First-Quarter 2022 Financial Results
Kronos Bio Reports Recent Business Progress and First-Quarter 2022 Financial Results
Post navigation
Previous Post
Previous
Blueprint Medicines Reports First Quarter 2022 Results
Next Post
Next
Turning Point Therapeutics Announces Pipeline Expansion, Licensing of TPX-4589 (LM-302), A Clinical Stage Anti-Claudin18.2 Antibody Drug Conjugate for Gastrointestinal Cancers, From Lanova Medicines